Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma
Open Access
- 4 June 2025
- journal article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 13 (6) , e011717
Abstract
Background Few studies have focused on the development of multiple myeloma (MM)-specific immunotherapies. Tumor immunogenic cell death (ICD), triggered by damage-associated molecular patterns, may enhance MM-specific antitumor activity, offering a potential treatment strategy. Methods This study confirms that combining reactive oxygen species (ROS)-endoplasmic reticulum stress (ERS) and pyroptosis-inducers (ROS-ERS inducer 1 (REI) and Quillaja saponaria fraction 21 (QS-21), respectively) activates specific anti-MM immunity. MM cell lines were treated with REI and QS-21 alone or in combination and cytotoxicity and apoptosis were examined. ICD markers were identified, including calreticulin, ATP, heat shock protein 70, and high mobility group box 1. Additionally, changes in mitochondrial damage, endoplasmic reticulum stress, pyroptosis markers, and immune markers of dendritic cell (DC) maturation and T-cell activation were assessed both in vitro and in vivo. Results ROS-ERS combined with pyroptosis significantly induces MM cell apoptosis and enhances ICD marker activation. The combination treatment induces severe mitochondrial damage and endoplasmic reticulum stress, further promoting pyroptosis and MM-specific T-cell activation. In vivo, the combination treatment reduces tumor growth and improves DC and T-cell activation. Conclusions Thus, ROS-ERS inducers and pyroptosis inducers together significantly enhance the immunogenic response against MM, providing a promising strategy for MM treatment by activating powerful specific T-cell antitumor immunity.Keywords
Funding Information
- the National Natural Science Foundation Project (grant no.82270142,81900131)
- Tianjin Municipal Natural Science Foundation (grant no. 23JCQNJC00870)
- Tianjin Municipal Health Commission Project (grant no. TJWJ2023XK003)
- The Ministry of science and Technology (grant no.2024YFC2510500)
- the Tianjin Science and Technology Planning Project (24ZXGQSY00020, grant no. 24ZXGZSY00090)
- China Postdoctoral Science Foundation (2023M742624)
- the Tianjin Municipal Natural Science Foundation (grant no. 24ZGSSSS00050)
This publication has 61 references indexed in Scilit:
- Kaempferol induces mitochondrial dysfunction and mitophagy by activating the LKB1/AMPK/MFF pathway in breast precancerous lesionsPhytotherapy Research, 2023
- BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple MyelomaAdvanced Materials, 2022
- Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy EfficiencyAdvanced Science, 2022
- Nanozyme-Based Enhanced Cancer ImmunotherapyTissue Engineering and Regenerative Medicine, 2022
- In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shiftBiomaterials, 2021
- Smart J-aggregate of cyanine photosensitizer with the ability to target tumor and enhance photodynamic therapy efficacyBiomaterials, 2021
- Endoplasmic Reticulum Stress Signaling in Cancer CellsThe American Journal of Pathology, 2020
- CD57 in human natural killer cells and T-lymphocytesCancer Immunology, Immunotherapy, 2016
- Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypesCancer Immunology, Immunotherapy, 2012
- Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimerBiomaterials, 2010